AP

APPLIED DNA SCIENCES INC

Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.

APDN | NDAQ

Overview

Corporate Details

ISIN(s):
US03815U3005
LEI:
Country:
United States of America
Address:
50 HEALTH SCIENCES DRIVE, 11790 STONY BROOK
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Applied DNA Sciences is a biotechnology company that develops and commercializes DNA-based technologies. Its primary focus is on advancing genetic medicine through the development and manufacture of its proprietary lineaDNA™ platform. Leveraging expertise in polymerase chain reaction (PCR) and enzymatic DNA synthesis, lineaDNA™ is designed for use in mRNA production, gene therapy, and cell therapy applications. The company also operates in molecular diagnostic (MDx) testing services and provides DNA-tagging security solutions for supply chain authentication and anti-counterfeiting to protect products and intellectual property.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all APPLIED DNA SCIENCES INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for APPLIED DNA SCIENCES INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for APPLIED DNA SCIENCES INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CDT Equity Inc. Logo
Clinical-stage biopharma using AI to enhance and advance therapies for unmet medical needs.
United States of America CDT
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Celcuity Inc. Logo
Developing targeted PI3K/mTOR inhibitor therapies for breast and prostate solid tumors.
United States of America CELC
Celemics, Inc. Logo
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
South Korea 331920
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
South Korea 308430
CELL BIOTECH CO ., LTD Logo
A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.
South Korea 049960
Celldex Therapeutics, Inc. Logo
Develops antibody-based therapies for severe inflammatory, allergic, and autoimmune diseases.
United States of America CLDX
Cellectar Biosciences, Inc. Logo
Late-stage biopharma developing targeted cancer therapies with a proprietary PDC delivery platform.
United States of America CLRB
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS
Cellectis S.A. Logo
Developing allogeneic CAR T-cell cancer immunotherapies using TALEN® gene-editing technology.
United States of America CLLS

Talk to a Data Expert

Have a question? We'll get back to you promptly.